# The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis

> **NCT00329680** · PHASE4 · COMPLETED · sponsor: **Fernandes Tavora Hospital** · enrollment: 115 (actual)

## Conditions studied

- Sepsis
- Severe Sepsis
- Septic Shock

## Interventions

- **DIETARY_SUPPLEMENT:** Eicosapentaenoic acid, Gamma-Linolenic Acid and Antioxidant Vitamins
- **DIETARY_SUPPLEMENT:** Standard ICU enteral diet, isocaloric to the study diet

## Key facts

- **NCT ID:** NCT00329680
- **Lead sponsor:** Fernandes Tavora Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2008-12
- **Final completion:** 2009-10
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2009-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329680

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329680, "The Effects of Eicosapentaenoic Acid (EPA), Gamma-Linolenic Acid (GLA) and Antioxidants in the Treatment of Sepsis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00329680. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*